Regulators say the nation's largest pharmacy benefit managers are partly to blame for the soaring cost of insulin in the U.S.

The Federal Trade Commission on Friday filed lawsuits against three prescription drug benefit managers or PBMs over concerns ...

The Federal Trade Commission sued the drug middlemen that health plans use to keep a lid on drug spending, accusing the firms ...

The agency alleges CVS’s Caremark, Cigna’s Express Scripts and UnitedHealth’s Optum Rx accepted money from drugmakers in ...

The three price benefit managers jointly administer 80% of all prescriptions in the U.S., the FTC said in the lawsuit.

The U.S. Federal Trade Commission sued the country's three largest pharmacy benefit managers on Friday, accusing them of ...

The Federal Trade Commission took action Friday against the three largest pharmacy benefit managers, accusing the companies ...

The suit accuses the "Big Three" of steering diabetes patients toward high-priced insulin to benefit their bottom lines ...

Insulin, used by millions of Americans, has taken center stage in the high-stakes battle over health care costs. Though ...

UnitedHealth Group division calls the action “baseless” and shows “profound misunderstanding” of drug pricing.

The FTC sued UnitedHealth Group’s Optum unit, CVS Caremark and Cigna’s Express Scripts for allegedly steering diabetes ...

The Federal Trade Commission (FTC) has filed a legal complaint accusing the 3 largest pharmacy benefit managers (PBMs) in the ...